DELRAY BEACH, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL BRAIN RESEARCH FOUNDATION INC, founded in 2005, is a small nonprofit in the Medical Research sector that reported $613K in total revenue in fiscal year 2023. Revenue fell 30% from the prior year — a significant decline worth monitoring. Expenses of $709K exceeded revenue, resulting in a 16% operating deficit.
IBRF'S MISSION IS MULTIFACETED, WITH A VISION TOWARD ADVANCING CUTTING-EDGE BRAIN DISCOVERIES FOR APPLICATION IN DIAGNOSIS AND TREATMENT.* RESEARCH: TO ENCOURAGE, SUPPORT, DESIGN, CONDUCT, AND DIRECT NOVEL NEUROSCIENTIFIC RESEARCH STUDIES WORLDWIDE.* EDUCATION: TO PROVIDE STATE-OF-THE ART TRAINING, EDUCATIONAL PROGRAMMING, LECTURE SERIES, RESEARCH PRESENTATIONS, AND CONFERENCES THAT SHARE GROUNDBREAKING RESEARCH FINDINGS AND NOVEL, THEORETICAL DIAGNOSTIC/TREATMENT PARADIGMS IN THE NEUROSCIENCES.* TECHNOLOGICAL ADVANCEMENT: TO DEVELOP NEW, INNOVATIVE BRAIN MAPPING, IMAGING, AND DIAGNOSTIC TECHNOLOGY TO ADVANCE THE TREATMENT OF BRAIN INJURY, DISORDERS, DISEASES, AND DYSFUNCTION.* INTERNATIONAL AND MULTI-CENTER COLLABORATION: TO CREATE HIGHLY FUNCTIONING NETWORKS OF COLLABORATIVE RESEARCH RELATIONSHIPS THAT CONNECT MULTIDISCIPLINARY TEAMS OF INTERNATIONAL EXPERTS ACROSS A VARIETY OF RESEARCH AND TREATMENT VENUES.
SEVERE DISORDERS OF CONSCIOUSNESS:IBRF HAS DEVELOPED DR. DEFINA'S ADVANCED CARE PROTOCOL/MULTICARE PROTOCOL (ACP/MCP) THAT UTILIZES TARGETED NEUROMODULATION PROCEDURES TO NORMALIZE THE BRAIN'S...
SEVERE DISORDERS OF CONSCIOUSNESS:IBRF HAS DEVELOPED DR. DEFINA'S ADVANCED CARE PROTOCOL/MULTICARE PROTOCOL (ACP/MCP) THAT UTILIZES TARGETED NEUROMODULATION PROCEDURES TO NORMALIZE THE BRAIN'S ELECTROCHEMICAL ENVIRONMENT TO IMPROVE BRAIN FUNCTION. THIS YEAR, IBRF PLACED SDOC PROGRAMS IN A VARIETY OF HOSPITAL/NURSING/REHAB FACILITIES WITH IMPLEMENTATION OF THE PROTOCOL. THESE SITES WERE BOTH INTHE UNITED STATES AND ABROAD. IBRF HAS FORGED NEW COLLABORATIONS WITH MEDICAL COMMUNITIES IN SAUDI ARABIA, MORROCO, UNITED ARAB EMIRATES, AND CUBA.
TRAUMATIC BRAIN INJURY:IBRF CONTINUES TO WORK COLLABORATIVELY IN RESEARCH WITH DR. MAX HILZ OF NYU AND DR. ALVARO PASCUAL-LEONE OF HARVARD UNIVERSITY FOR IMPROVED TREATMENTS FOR TRAUMATIC BRAIN...
TRAUMATIC BRAIN INJURY:IBRF CONTINUES TO WORK COLLABORATIVELY IN RESEARCH WITH DR. MAX HILZ OF NYU AND DR. ALVARO PASCUAL-LEONE OF HARVARD UNIVERSITY FOR IMPROVED TREATMENTS FOR TRAUMATIC BRAIN INJURY. DIAGNOSTIC AND TREATMENT TOOLS SUCH AS ANS (AUTONOMIC NERVOUS SYSTEM MONITORING) AND TMS (TRANSCRANIAL MAGNETIC STIMULATION) ARE BEING VALIDATED AS TWO OF THE MOST PROMINENT TOOLS TO TACKLE THE COMPLEXITIES OF TRAUMATIC BRAIN INJURY AND SUDDEN DEATH SYNDROME.DRS. PHILIP SCHATZ AND ROSEMARIE MOSER CONTINUE TO MAKE ADVANCES IN THE AREA OF MILD TRAUMATIC BRAIN INJURY AND SPORTS CONCUSSION. THEY CO-AUTHORED A LANDMARK ARTICLE THAT WAS PUBLISHED IN THE JOURNAL OF PEDIATRICS, THE FIRST EMPIRICAL STUDY TO DOCUMENT EFFICACY OF THE USE OF COGNITIVE AND PHYSICAL REST AS TREATMENT IN CONCUSSION. THIS WAS ALSO PRESENTED AS PART OF THE 4TH INTERNATIONAL CONSENSUS CONFERENCE ON CONCUSSION IN SPORT IN ZURICH, SWITZERLAND.DR. ROSEMARIE MOSER WAS APPOINTED TO THE EXPERT PANEL ON PEDIATRIC TRAUMATIC BRAIN INJURY OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEVELOP U.S. STANDARDS.IBRF FOCUSED ON DEVELOPING RESEARCH PROTOCOLS FOR MILD TRAUMATIC BRAIN INJURY AND POST-TRAUMATIC STRESS DISORDER IN THE MILITARY. THIS WAS PROMPTED BY THE REQUEST OF THE U.S. ARMY.
NEURODEGENERATIVE, DEVELOPMENTAL, AND RELATED DISORDERS:IBRF HAS BEGUN RESEARCH IN THE USE OF INFRARED LIGHT THERAPY COMBINED WITH NUTRACEUTICALS AND ELECTRICAL STIMULATION PROTOCOLS AND...
NEURODEGENERATIVE, DEVELOPMENTAL, AND RELATED DISORDERS:IBRF HAS BEGUN RESEARCH IN THE USE OF INFRARED LIGHT THERAPY COMBINED WITH NUTRACEUTICALS AND ELECTRICAL STIMULATION PROTOCOLS AND NEUROFEEDBACK FOR DEMENTIA. IBRF CONTINUES INTERNATIONAL COLLABORATIONS TO CONDUCT RESEARCH ON NEUROPHYSIOLOGICAL DIAGNOSTIC AND TREATMENT MODALITIES IN THIS AREA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $612,630 | $880,096 | -0.3% |
| Expenses | $708,892 | $1,349,927 | -0.5% |
| Net Income | $-96,262 | $-469,831 | -0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PHILIP DEFINA | CEO/CSO | 60.00 |
Officer
Director
|
$153,846 | $0 | $153,846 |
| DR SUSAN ADLER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| DR CHARLES PRESTIGIACOMO | VICE CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| TAMMY FISHER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| GREGORY SIORIS ESQ | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| RICHARD GASPRI | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $612,630 | $708,892 | $294,673 | $-96,262 |
| 2022 | $880,096 | $1,349,927 | $390,935 | $-469,831 |
| 2021 | $1,665,648 | $1,226,236 | $850,583 | $439,412 |
| 2020 | $1,095,640 | $737,788 | $468,177 | $357,852 |
| 2019 | $601,229 | $611,471 | $404,272 | $-10,242 |
| 2018 | $580,913 | $371,649 | $414,514 | $209,264 |
Compare INTERNATIONAL BRAIN RESEARCH FOUNDATION INC with other nonprofits in Florida and across the country.